Insider trades
Dean J. Mitchell, Director of Theravance Biopharma TBPH, has filed 2 purchases and 0 sales on the open market. The latest trade was on 09/23.
Dean J. Mitchell
Director
- Company
- Theravance Biopharma TBPH
- First filing
- 23/01/04
- Trades
- 62 trades
- Buys / sales
- 2 / 0
- 12-month net buying
- No record
- Last trade
- 09/23
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
PrecigenPGEN | Open-market buy | 23/09/22 | 23/09/25 | 25,000 sh | $1.41 | $35,250 | +7.5% |
| Open-market buy | 23/03/24 | 23/03/27 | 50,000 sh | $0.84 | $42,000 | +200.0% |